Welcome to the AAP experience. Visit us at Booth 351
Verrica Pharmaceuticals Inc. is a medical dermatology company committed to the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases.
Our lead product candidate, VP-102, is a proprietary drug-device combination of our novel topical solution of cantharidin, a widely recognized, naturally sourced agent to treat topical dermatological conditions, clinically administered through our single-use precision applicator. We are initially developing VP-102 for the treatment of molluscum contagiosum, a highly contagious viral skin infection affecting approximately six million people, primarily children, in the United States, and common warts. There are currently no products approved by the U.S. Food and Drug Administration.